Tag: FDA

February 17, 2024
FDA Approves First Test to Help Identify Risks of Developing Opioid Use Disorder

The AvertD test is intended to be used prior to first exposure to oral opioids in patients considered for a 4-30 day prescription for acute pain.

READ MORE
November 12, 2023
FDA Warns of Risks with Compounded Ketamine Products

The ketamine molecule is not FDA-approved in any formulation for the treatment of psychiatric disorders.

READ MORE
November 17, 2022
Wave of Generic Approvals That Impact Workers’ Comp

First-time generics are available for drugs that treat COPD, HIV, hypertension, and more.

READ MORE
September 25, 2022
FDA Authorizes Additional Round of COVID-19 Boosters

Moderna and Pfizer boosters have been updated to target the omicron variant.

READ MORE
August 25, 2022
FDA Authorizes New COVID-19 Vaccine

Novavax COVID-19 Vaccine, Adjuvanted will require two doses given three weeks apart.

READ MORE
July 20, 2022
FDA Recalls Morphine Sulfate ER Due to Potentially Deadly Label Mix-Up

A mix-up between 30 mg and 60 mg tablets could cause severe adverse events.

READ MORE
May 18, 2022
FDA Issues Warning for Consumer Products with Hidden Pain Medications

Undeclared muscle relaxants and anti-inflammatory drugs could interact with a patient’s care.

READ MORE
May 15, 2022
FDA Considers Requiring Mail-Back Envelopes for Opioid Prescriptions

The public comment period is underway for this action, which could help with safer drug disposal.

READ MORE
February 21, 2022
FDA Issues Warning for Dental Problems with Dissolvable Buprenorphine Products

Buprenorphine is an opioid used to treat pain, as well as opioid-use disorder.

READ MORE
December 20, 2021
COVID-19 Pill Approval and More Updates

Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.

READ MORE
1 2 3 7
lockenvelopephone-handsetmagnifiermenucross-circle